Gemina Laboratories Ltd. (GLABF)
USD 0.92
(17.08%)
USD 0.92
(17.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -5.08 Million CAD | 14.95% |
| 2023 | -5.98 Million CAD | -26.31% |
| 2022 | -4.73 Million CAD | -633.33% |
| 2021 | -645.6 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.7 Million CAD | 12.71% |
| 2024 FY | -5.19 Million CAD | 13.09% |
| 2024 Q4 | -1.03 Million CAD | -17.21% |
| 2024 Q3 | -886.05 Thousand CAD | 43.85% |
| 2024 Q2 | -1.57 Million CAD | 7.65% |
| 2023 Q4 | -1.95 Million CAD | -56.46% |
| 2023 Q1 | -780.77 Thousand CAD | 40.28% |
| 2023 Q2 | -1.99 Million CAD | -154.92% |
| 2023 FY | -5.98 Million CAD | -26.31% |
| 2023 Q3 | -1.25 Million CAD | 37.13% |
| 2022 Q3 | -1.51 Million CAD | -98.2% |
| 2022 Q2 | -766.34 Thousand CAD | 32.96% |
| 2022 Q1 | -1.14 Million CAD | -152.36% |
| 2022 FY | -4.73 Million CAD | -633.33% |
| 2022 Q4 | -1.3 Million CAD | 13.93% |
| 2021 FY | -645.6 Thousand CAD | 0.0% |
| 2021 Q2 | -52.67 Thousand CAD | 0.0% |
| 2021 Q3 | -163.99 Thousand CAD | -211.34% |
| 2021 Q4 | -452.99 Thousand CAD | -176.23% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Capstone Therapeutics Corp. | -1.25 Million USD | -304.927% |
| Skye Bioscience, Inc. | -13.67 Million USD | 62.8% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 106.214% |
| Nascent Biotech, Inc. | -2.22 Million USD | -128.079% |
| Qrons Inc. | -643.67 Thousand USD | -690.13% |
| Adynxx, Inc. | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | 34.62% |
| CSL Limited | 3.7 Billion USD | 100.137% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 71.503% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -0.821% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -640.357% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 90.838% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1124.101% |
| Rebus Holdings, Inc. | -664 Thousand USD | -665.946% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -280.842% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -1205.512% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 67.952% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 92.915% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 203.481% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -1843.209% |
| SQZ Biotechnologies Company | -75.82 Million USD | 93.293% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -78.42% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -231.102% |
| Mesoblast Limited | -84.14 Million USD | 93.956% |
| Marizyme, Inc. | -34.08 Million USD | 85.079% |
| Genus plc | 6.4 Million USD | 179.467% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 152.203% |
| Pharming Group N.V. | -4.87 Million USD | -4.229% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -156.025% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -446.059% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 39.091% |
| ContraFect Corporation | -56.88 Million USD | 91.06% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -11.662% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -262.761% |
| IMV Inc. | -38.67 Million USD | 86.849% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -84.885% |
| MultiCell Technologies, Inc. | -722.81 USD | -703526.541% |
| ONE Bio Corp. | 13.68 Million USD | 137.173% |
| Accustem Sciences Inc. | -3.74 Million USD | -35.753% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 91.378% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -952.843% |
| Q BioMed Inc. | -3.44 Million USD | -47.604% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 243.669% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -93.562% |
| Biomind Labs Inc. | -1 Million USD | -403.751% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 90.748% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -75.3% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 23.498% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -172.794% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -16880.112% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -163.161% |
| GB Sciences, Inc. | -1.42 Million USD | -258.032% |
| Alpha Cognition Inc. | -9.7 Million USD | 47.598% |
| HST Global, Inc. | -140.9 Thousand USD | -3509.39% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -352.116% |
| Halberd Corporation | -75.05 Thousand USD | -6676.66% |
| Enzolytics Inc. | -2.14 Million USD | -136.685% |
| Agentix Corp. | -1.37 Million USD | -270.757% |
| Resverlogix Corp. | -12.74 Million USD | 60.108% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -60.525% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 98.803% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -387.154% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -74.207% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -222.023% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -49.366% |
| AVAX Technologies, Inc. | 6.69 Million USD | 175.989% |
| Zenith Capital Corp. | -8.94 Million USD | 43.13% |
| Genscript Biotech Corporation | -415.79 Million USD | 98.777% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -29093.979% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -107.138% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -2865.364% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -153.691% |
| Kadimastem Ltd | -3.04 Million USD | -67.285% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -416.83% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -2702.371% |
| LadRx Corporation | -3.82 Million USD | -33.012% |
| Cell Source, Inc. | -4.32 Million USD | -17.583% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -640.357% |
| NovAccess Global Inc. | -2.46 Million USD | -106.177% |
| Affymax, Inc. | -15.04 Million USD | 66.198% |
| Itoco Inc. | -919.14 Thousand USD | -453.331% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -19.995% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -354.503% |
| Mobile Lads Corp. | -554.55 Thousand USD | -817.119% |
| CytoDyn Inc. | -18.05 Million USD | 71.836% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -20106.13% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -2210.946% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -800.598% |
| SYBLEU INC | -149.18 Thousand USD | -3309.226% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -180.01% |
| International Stem Cell Corporation | -663 Thousand USD | -667.102% |
| Bioxytran, Inc. | -3.82 Million USD | -33.133% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -9561.632% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -24904.341% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 85.976% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -214.331% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -591.172% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -63.481% |
| Neutra Corp. | -229.48 Thousand USD | -2116.206% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 71.002% |
| PureTech Health plc | -146.19 Million USD | 96.521% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 76.335% |
| IXICO plc | -1.43 Million USD | -253.924% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 46.414% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 95.825% |
| CSL Limited | 3.81 Billion USD | 100.133% |
| Cellectis S.A. | -108.85 Million USD | 95.328% |